MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,600.751K
EPS
-$0.07
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-11-30
2025-08-31
Revenue
0
177*
Cost of goods sold
0
1*
Gross profit
0
176*
Research and development
671.34
2,059*
General and administrative
902.291
1,086*
Total operating expenses
1,573.631
3,145*
Loss from operations
-1,573.631
-2,969*
Interest income
0.012
1*
Unrealized loss on marketable securities
-22.093
-9*
Total other income (loss)
-22.081
-8*
Net loss before income taxes
-1,595.712
-
Income taxes
1.791
-
Net loss
-1,597.503
-2,977*
Less net loss attributable to non-controlling interest
-2.496
-2*
Net loss attributable to lexaria shareholders
-1,595.007
-2,975*
Foreign currency translation adjustment
-5.744
-13*
Total comprehensive loss
-1,600.751
-2,988
Diluted EPS
-0.07
-0.166
Diluted Average Shares
21,376,029
17,998,715
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$1,600.751K
Net loss
attributable to lexaria...
-$1,595.007K
Foreign currency
translation adjustment
-$5.744K
Less net loss
attributable to...
-$2.496K
Net loss
-$1,597.503K
Net loss before
income taxes
-$1,595.712K
Income taxes
$1.791K
Loss from operations
-$1,573.631K
Total other income
(loss)
-$22.081K
Interest income
$0.012K
Total operating
expenses
$1,573.631K
Unrealized loss on
marketable securities
-$22.093K
General and
administrative
$902.291K
Research and development
$671.34K
Buy us a coffee
Lexaria Bioscience Corp. (LEXXW)
Lexaria Bioscience Corp. (LEXXW)